<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-04-26" modified="2020-10-07" version="181">
<accession>O43255</accession>
<accession>O43270</accession>
<name>SIAH2_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 ubiquitin-protein ligase SIAH2</fullName>
<ecNumber>2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="18">RING-type E3 ubiquitin transferase SIAH2</fullName>
</alternativeName>
<alternativeName>
<fullName>Seven in absentia homolog 2</fullName>
<shortName>Siah-2</shortName>
<shortName>hSiah2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">SIAH2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Genomics" volume="46" first="103" last="111">
<title>Characterization of human homologs of the Drosophila seven in absentia (sina) gene.</title>
<authorList>
<person name="Hu G."/>
<person name="Chung Y.-L."/>
<person name="Glover T."/>
<person name="Valentine V."/>
<person name="Look A.T."/>
<person name="Fearon E.R."/>
</authorList>
<dbReference type="PubMed" id="9403064"/>
<dbReference type="DOI" id="10.1006/geno.1997.4997"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="3798" last="3807">
<title>hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways.</title>
<authorList>
<person name="Germani A."/>
<person name="Romero F."/>
<person name="Houlard M."/>
<person name="Camonis J."/>
<person name="Gisselbrecht S."/>
<person name="Fischer S."/>
<person name="Varin-Blank N."/>
</authorList>
<dbReference type="PubMed" id="10207103"/>
<dbReference type="DOI" id="10.1128/mcb.19.5.3798"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>INTERACTION WITH VAV1</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="Genes Dev." volume="11" first="2701" last="2714">
<title>Mammalian homologs of seven in absentia regulate DCC via the ubiquitin-proteasome pathway.</title>
<authorList>
<person name="Hu G."/>
<person name="Zhang S."/>
<person name="Vidal M."/>
<person name="Baer J.L."/>
<person name="Xu T."/>
<person name="Fearon E.R."/>
</authorList>
<dbReference type="PubMed" id="9334332"/>
<dbReference type="DOI" id="10.1101/gad.11.20.2701"/>
</citation>
<scope>FUNCTION IN DEGRADATION OF DCC</scope>
<scope>INTERACTION WITH UBE2I AND DCC</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="4153" last="4162">
<title>Regulation of BOB.1/OBF.1 stability by SIAH.</title>
<authorList>
<person name="Boehm J."/>
<person name="He Y."/>
<person name="Greiner A."/>
<person name="Staudt L."/>
<person name="Wirth T."/>
</authorList>
<dbReference type="PubMed" id="11483518"/>
<dbReference type="DOI" id="10.1093/emboj/20.15.4153"/>
</citation>
<scope>FUNCTION IN DEGRADATION OF POU2AF1</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Mol. Cell" volume="7" first="915" last="926">
<title>Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses.</title>
<authorList>
<person name="Matsuzawa S."/>
<person name="Reed J.C."/>
</authorList>
<dbReference type="PubMed" id="11389839"/>
<dbReference type="DOI" id="10.1016/s1097-2765(01)00242-8"/>
</citation>
<scope>INTERACTION WITH CACYBP</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="5756" last="5765">
<title>Stress-induced decrease in TRAF2 stability is mediated by Siah2.</title>
<authorList>
<person name="Habelhah H."/>
<person name="Frew I.J."/>
<person name="Laine A."/>
<person name="Janes P.W."/>
<person name="Relaix F."/>
<person name="Sassoon D."/>
<person name="Bowtell D.D.L."/>
<person name="Ronai Z."/>
</authorList>
<dbReference type="PubMed" id="12411493"/>
<dbReference type="DOI" id="10.1093/emboj/cdf576"/>
</citation>
<scope>FUNCTION IN DEGRADATION OF TRAF2</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="3043" last="3048">
<title>Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1.</title>
<authorList>
<person name="Okabe H."/>
<person name="Satoh S."/>
<person name="Furukawa Y."/>
<person name="Kato T."/>
<person name="Hasegawa S."/>
<person name="Nakajima Y."/>
<person name="Yamaoka Y."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="12810624"/>
</citation>
<scope>INTERACTION WITH PEG10</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Biochem. J." volume="397" first="179" last="186">
<title>Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation.</title>
<authorList>
<person name="Tian Y.M."/>
<person name="Mole D.R."/>
<person name="Ratcliffe P.J."/>
<person name="Gleadle J.M."/>
</authorList>
<dbReference type="PubMed" id="16509823"/>
<dbReference type="DOI" id="10.1042/bj20051996"/>
</citation>
<scope>INTERACTION WITH EGLN2</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="11706" last="11716">
<title>Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates alpha-synuclein monoubiquitylation and inclusion formation.</title>
<authorList>
<person name="Szargel R."/>
<person name="Rott R."/>
<person name="Eyal A."/>
<person name="Haskin J."/>
<person name="Shani V."/>
<person name="Balan L."/>
<person name="Wolosker H."/>
<person name="Engelender S."/>
</authorList>
<dbReference type="PubMed" id="19224863"/>
<dbReference type="DOI" id="10.1074/jbc.m805990200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SNCAIP</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2012" name="J. Mol. Cell Biol." volume="4" first="316" last="330">
<title>Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways.</title>
<authorList>
<person name="Perez M."/>
<person name="Garcia-Limones C."/>
<person name="Zapico I."/>
<person name="Marina A."/>
<person name="Schmitz M.L."/>
<person name="Munoz E."/>
<person name="Calzado M.A."/>
</authorList>
<dbReference type="PubMed" id="22878263"/>
<dbReference type="DOI" id="10.1093/jmcb/mjs047"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DYRK2</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-16; THR-26; SER-28; SER-68 AND THR-119</scope>
<scope>MUTAGENESIS OF SER-16; THR-26; SER-28; SER-68 AND THR-119</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2015" name="Proc. Natl. Acad. Sci. U.S.A." volume="112" first="12420" last="12425">
<title>Ubiquitin ligase Siah2 regulates RevErbalpha degradation and the mammalian circadian clock.</title>
<authorList>
<person name="DeBruyne J.P."/>
<person name="Baggs J.E."/>
<person name="Sato T.K."/>
<person name="Hogenesch J.B."/>
</authorList>
<dbReference type="PubMed" id="26392558"/>
<dbReference type="DOI" id="10.1073/pnas.1501204112"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NR1D1 AND NR1D2</scope>
</reference>
<comment type="function">
<text evidence="4 9 10 13 14 15 16">E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:9334332, PubMed:11483518, PubMed:19224863). E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates (PubMed:9334332, PubMed:11483518, PubMed:19224863). Mediates E3 ubiquitin ligase activity either through direct binding to substrates or by functioning as the essential RING domain subunit of larger E3 complexes (PubMed:9334332, PubMed:11483518, PubMed:19224863). Triggers the ubiquitin-mediated degradation of many substrates, including proteins involved in transcription regulation (GPS2, POU2AF1, PML, NCOR1), a cell surface receptor (DCC), an antiapoptotic protein (BAG1), and a protein involved in synaptic vesicle function in neurons (SYP) (PubMed:9334332, PubMed:11483518, PubMed:19224863). Mediates ubiquitination and proteasomal degradation of DYRK2 in response to hypoxia (PubMed:22878263). It is thereby involved in apoptosis, tumor suppression, cell cycle, transcription and signaling processes (PubMed:9334332, PubMed:11483518, PubMed:19224863, PubMed:22878263). Has some overlapping function with SIAH1 (PubMed:9334332, PubMed:11483518, PubMed:19224863). Triggers the ubiquitin-mediated degradation of TRAF2, whereas SIAH1 does not (PubMed:12411493). Promotes monoubiquitination of SNCA (PubMed:19224863). Regulates cellular clock function via ubiquitination of the circadian transcriptional repressors NR1D1 and NR1D2 leading to their proteasomal degradation (PubMed:26392558). Plays an important role in mediating the rhythmic degradation/clearance of NR1D1 and NR1D2 contributing to their circadian profile of protein abundance (PubMed:26392558). Mediates ubiquitination and degradation of EGLN2 and EGLN3 in response to the unfolded protein response (UPR), leading to their degradation and subsequent stabilization of ATF4 (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction>
<text>S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
<dbReference type="EC" id="2.3.2.27"/>
</reaction>
</comment>
<comment type="activity regulation">
<text evidence="13">Inhibited by interaction with SNCAIP (isoform 2, but not isoform 1). May be inhibited by interaction with PEG10.</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="4 7 8 11 12 13 14 15 16">Homodimer. Interacts with UBE2E2. Interacts with PEG3 (By similarity). Interacts with VAV1, without mediating its ubiquitin-mediated degradation. Interacts with CACYBP/SIP. Probable component of some large E3 complex possibly composed of UBE2D1, SIAH2, CACYBP/SIP, SKP1, APC and TBL1X. Interacts with PEG10, which may inhibit its activity. Interacts with EGLN2 and SNCAIP. Interacts with DYRK2. Interacts with NR1D1 and NR1D2 (PubMed:26392558). Interacts with DCC (PubMed:9334332).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-948141">
<id>O43255</id>
</interactant>
<interactant intactId="EBI-444209">
<id>O95835</id>
<label>LATS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-948141">
<id>O43255</id>
</interactant>
<interactant intactId="EBI-3506895">
<id>Q9NRM7</id>
<label>LATS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-948141">
<id>O43255</id>
</interactant>
<interactant intactId="EBI-2624570">
<id>P35372</id>
<label>OPRM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-948141">
<id>O43255</id>
</interactant>
<interactant intactId="EBI-311339">
<id>Q7Z6J0</id>
<label>SH3RF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13 14">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="14">Nucleus</location>
</subcellularLocation>
<text evidence="14">Predominantly cytoplasmic. Partially nuclear.</text>
</comment>
<comment type="tissue specificity">
<text evidence="17">Widely expressed at low level.</text>
</comment>
<comment type="domain">
<text>The RING-type zinc finger domain is essential for ubiquitin ligase activity.</text>
</comment>
<comment type="domain">
<text evidence="3">The SBD domain (substrate-binding domain) mediates the homodimerization and the interaction with substrate proteins. It is related to the TRAF family.</text>
</comment>
<comment type="PTM">
<text evidence="4 14">Phosphorylated at Ser-28 by MAPK14, which mediates the degradation by the proteasome of EGLN3 (By similarity). Phosphorylated at Ser-28 by DYRK2; this increases the ubiquitin ligase activity and promotes degradation of EGLN3.</text>
</comment>
<comment type="similarity">
<text evidence="18">Belongs to the SINA (Seven in absentia) family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/SIAH2ID46199ch3q25.html"/>
</comment>
<dbReference type="EC" id="2.3.2.27"/>
<dbReference type="EMBL" id="U76248">
<property type="protein sequence ID" value="AAC51908.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Y15268">
<property type="protein sequence ID" value="CAA75557.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC013082">
<property type="protein sequence ID" value="AAH13082.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3152.1"/>
<dbReference type="RefSeq" id="NP_005058.3">
<property type="nucleotide sequence ID" value="NM_005067.5"/>
</dbReference>
<dbReference type="PDB" id="5H9M">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.76"/>
<property type="chains" value="A/B=131-321"/>
</dbReference>
<dbReference type="PDBsum" id="5H9M"/>
<dbReference type="SMR" id="O43255"/>
<dbReference type="BioGRID" id="112373">
<property type="interactions" value="80"/>
</dbReference>
<dbReference type="CORUM" id="O43255"/>
<dbReference type="DIP" id="DIP-41874N"/>
<dbReference type="IntAct" id="O43255">
<property type="interactions" value="25"/>
</dbReference>
<dbReference type="MINT" id="O43255"/>
<dbReference type="STRING" id="9606.ENSP00000322457"/>
<dbReference type="TCDB" id="8.A.133.1.2">
<property type="family name" value="the siah1 e3 ubiquitin-protein ligase (siah1) family"/>
</dbReference>
<dbReference type="iPTMnet" id="O43255"/>
<dbReference type="PhosphoSitePlus" id="O43255"/>
<dbReference type="BioMuta" id="SIAH2"/>
<dbReference type="MassIVE" id="O43255"/>
<dbReference type="MaxQB" id="O43255"/>
<dbReference type="PaxDb" id="O43255"/>
<dbReference type="PeptideAtlas" id="O43255"/>
<dbReference type="PRIDE" id="O43255"/>
<dbReference type="ProteomicsDB" id="48838"/>
<dbReference type="Antibodypedia" id="33601">
<property type="antibodies" value="225 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000312960">
<property type="protein sequence ID" value="ENSP00000322457"/>
<property type="gene ID" value="ENSG00000181788"/>
</dbReference>
<dbReference type="GeneID" id="6478"/>
<dbReference type="KEGG" id="hsa:6478"/>
<dbReference type="UCSC" id="uc003eyi.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6478"/>
<dbReference type="DisGeNET" id="6478"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000181788.3"/>
<dbReference type="GeneCards" id="SIAH2"/>
<dbReference type="HGNC" id="HGNC:10858">
<property type="gene designation" value="SIAH2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000181788">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="602213">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O43255"/>
<dbReference type="OpenTargets" id="ENSG00000181788"/>
<dbReference type="PharmGKB" id="PA35760"/>
<dbReference type="eggNOG" id="KOG3002">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159812"/>
<dbReference type="HOGENOM" id="CLU_028215_0_0_1"/>
<dbReference type="InParanoid" id="O43255"/>
<dbReference type="KO" id="K08742"/>
<dbReference type="OMA" id="AGHLVCK"/>
<dbReference type="OrthoDB" id="780610at2759"/>
<dbReference type="PhylomeDB" id="O43255"/>
<dbReference type="TreeFam" id="TF312976"/>
<dbReference type="PathwayCommons" id="O43255"/>
<dbReference type="Reactome" id="R-HSA-373752">
<property type="pathway name" value="Netrin-1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-977225">
<property type="pathway name" value="Amyloid fiber formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983168">
<property type="pathway name" value="Antigen processing: Ubiquitination &amp; Proteasome degradation"/>
</dbReference>
<dbReference type="SIGNOR" id="O43255"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="BioGRID-ORCS" id="6478">
<property type="hits" value="6 hits in 877 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SIAH2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="SIAH2"/>
<dbReference type="GenomeRNAi" id="6478"/>
<dbReference type="Pharos" id="O43255">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O43255"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="RNAct" id="O43255">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000181788">
<property type="expression patterns" value="Expressed in adrenal tissue and 228 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O43255">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O43255">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005769">
<property type="term" value="C:early endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042025">
<property type="term" value="C:host cell nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0003714">
<property type="term" value="F:transcription corepressor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0031624">
<property type="term" value="F:ubiquitin conjugating enzyme binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0044257">
<property type="term" value="P:cellular protein catabolic process"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007275">
<property type="term" value="P:multicellular organism development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090090">
<property type="term" value="P:negative regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043154">
<property type="term" value="P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001237">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902842">
<property type="term" value="P:negative regulation of netrin-activated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042752">
<property type="term" value="P:regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031396">
<property type="term" value="P:regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048511">
<property type="term" value="P:rhythmic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007264">
<property type="term" value="P:small GTPase mediated signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006511">
<property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.210.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR018121">
<property type="entry name" value="7-in-absentia-prot_TRAF-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR004162">
<property type="entry name" value="SINA-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR008974">
<property type="entry name" value="TRAF-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR013010">
<property type="entry name" value="Znf_SIAH"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR45877">
<property type="entry name" value="PTHR45877"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03145">
<property type="entry name" value="Sina"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49599">
<property type="entry name" value="SSF49599"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51081">
<property type="entry name" value="ZF_SIAH"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="E3 ubiquitin-protein ligase SIAH2" id="PRO_0000056168">
<location>
<begin position="1"/>
<end position="324"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="5">
<location>
<begin position="80"/>
<end position="115"/>
</location>
</feature>
<feature type="zinc finger region" description="SIAH-type" evidence="6">
<location>
<begin position="133"/>
<end position="193"/>
</location>
</feature>
<feature type="region of interest" description="SBD" evidence="3">
<location>
<begin position="130"/>
<end position="322"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="3">
<location>
<position position="138"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="3">
<location>
<position position="145"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="3">
<location>
<position position="157"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="3">
<location>
<position position="161"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="3">
<location>
<position position="168"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="3">
<location>
<position position="175"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="3">
<location>
<position position="187"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="3">
<location>
<position position="192"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="6"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DYRK2" evidence="14">
<location>
<position position="16"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by DYRK2" evidence="14">
<location>
<position position="26"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DYRK2 and MAPK14" evidence="14">
<location>
<position position="28"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DYRK2" evidence="14">
<location>
<position position="68"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by DYRK2" evidence="14">
<location>
<position position="119"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation by DYRK2; when associated with A-26; A-28; A-68 and A-119." evidence="14">
<original>S</original>
<variation>A</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation by DYRK2; when associated with A-16; A-28; A-68 and A-119." evidence="14">
<original>T</original>
<variation>A</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation by DYRK2; when associated with A-16; A-26; A-68 and A-119." evidence="14">
<original>S</original>
<variation>A</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation by DYRK2; when associated with A-16; A-26; A-28 and A-119." evidence="14">
<original>S</original>
<variation>A</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation by DYRK2; when associated with A-16; A-26; A-28 and A-68." evidence="14">
<original>T</original>
<variation>A</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC51908." ref="1" evidence="18">
<original>G</original>
<variation>E</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="135"/>
<end position="137"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="141"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="148"/>
<end position="150"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="151"/>
<end position="153"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="154"/>
<end position="160"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="184"/>
<end position="191"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="196"/>
<end position="207"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="217"/>
<end position="224"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="227"/>
<end position="239"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="242"/>
<end position="253"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="255"/>
<end position="258"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="262"/>
<end position="269"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="272"/>
<end position="278"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="283"/>
<end position="285"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="288"/>
<end position="292"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="296"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="301"/>
<end position="307"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="312"/>
<end position="320"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5H9M"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P61092"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q06986"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00455"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10207103"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11389839"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11483518"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12411493"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12810624"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16509823"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19224863"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22878263"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26392558"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9334332"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9403064"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000305"/>
<sequence length="324" mass="34615" checksum="2D5DD845666EC924" modified="1998-06-01" version="1">MSRPSSTGPSANKPCSKQPPPQPQHTPSPAAPPAAATISAAGPGSSAVPAAAAVISGPGGGGGAGPVSPQHHELTSLFECPVCFDYVLPPILQCQAGHLVCNQCRQKLSCCPTCRGALTPSIRNLAMEKVASAVLFPCKYATTGCSLTLHHTEKPEHEDICEYRPYSCPCPGASCKWQGSLEAVMSHLMHAHKSITTLQGEDIVFLATDINLPGAVDWVMMQSCFGHHFMLVLEKQEKYEGHQQFFAIVLLIGTRKQAENFAYRLELNGNRRRLTWEATPRSIHDGVAAAIMNSDCLVFDTAIAHLFADNGNLGINVTISTCCP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

